S. Grandy

Matthew Reynolds, Susan Grandy, K. Coyne, 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Rate and risk predictors for development of self‐reported type‐2 diabetes mellitus over a 5‐year period: the SHIELD study

A. J. Green, H. Rodbard, S. Grandy, 2012, International journal of clinical practice.

Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany

S. Grandy, K. Kostev, K. Johnsson, 2017, Journal of diabetes science and technology.

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany

S. Grandy, K. Kostev, K. Johnsson, 2016, Diabetes, metabolic syndrome and obesity : targets and therapy.

Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study

A. Shaunik, S. Grandy, E. Flood, 2017, Diabetes Therapy.

The state of patient-reported outcomes in atrial fibrillation

K. Coyne, P. Zimetbaum, S. Grandy, 2012, PharmacoEconomics.

Affecting Behavior Change in Individuals With Diabetes Findings From the Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes (SHIELD)

Jennifer G. Robinson, K. Fox, S. Grandy, 2008, The Diabetes educator.

Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study

K. Fox, S. Grandy, 2012, Health and Quality of Life Outcomes.

Atherosclerosis profile and incidence of cardiovascular events: a population-based survey

Jennifer G. Robinson, Susan Grandy, K. Fox, 2009, BMC cardiovascular disorders.

S. Grandy, J. Sugg, S. Parikh, 2014, International journal of clinical practice.

Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD

H. Rodbard, K. Fox, S. Grandy, 2008, International journal of clinical practice.

Effects of Glucagon-Like Peptide-1 Receptor Agonists on β-Cell Function in Patients with Type 2 Diabetes

A. Shaunik, S. Grandy, É. Hardy, 2016 .

S. Grandy, J. Jackson, E. Palaka, 2021, International journal of clinical practice.

A. J. Green, S. Grandy, D. D. Bazata, 2007, International journal of clinical practice.

Understanding Patient Perspectives and Awareness of the Impact and Treatment of Anemia with Chronic Kidney Disease: A Patient Survey in China

S. Grandy, E. Wittbrodt, C. Hao, 2021, International journal of nephrology and renovascular disease.

Race/Ethnicity and gender differences in health intentions and behaviors regarding exercise and diet for adults with type 2 diabetes: A cross-sectional analysis

K. Fox, S. Grandy, J. Gavin, 2011, BMC public health.

Clinical and Patient-Related Variables Associated with Initiating GLP-1 Receptor Agonist Therapy in Type 2 Diabetes Patients in Primary Care in Germany

S. Grandy, K. Kostev, Q. Qiao, 2016, PloS one.

Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective

S. Grandy, M. Charokopou, D. Gibson, 2016, Journal of medical economics.

Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus: An Analysis from the UK NHS Perspective.

S. Grandy, M. Charokopou, D. Gibson, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes)

Susan Grandy, A. J. Green, N. Clark, 2007, BMC public health.

Cardiovascular event rates and healthcare resource utilisation among high‐risk adults with type 2 diabetes mellitus in a large population‐based study

S. Grandy, K. Fox, J. Kim, 2015, International journal of clinical practice.

Out-of-pocket expenses and healthcare resource utilization among individuals with or at risk of diabetes mellitus

K. Fox, S. Grandy, 2008 .

Weight Loss Impact on Change in Depression in Type 2 Diabetes Mellitus: Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes (SHIELD)

Susan Grandy, Andrew J. Green, Kathleen M. Fox, 2014 .

PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus: Evidence from a Dutch Cohort

R. Herings, S. Grandy, S. Parasuraman, 2011 .

Impact of Regular Exercise and Attempted Weight Loss on Quality of Life among Adults with and without Type 2 Diabetes Mellitus

A. J. Green, K. Fox, S. Grandy, 2010, Journal of obesity.

PDB52 ATTEMPTED WEIGHT LOSS OR REGULAR EXERCISE: IMPACT ON QUALITY OF LIFE AMONG ADULTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS

A. J. Green, K. Fox, S. Grandy, 2010 .

Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses.

A. J. Green, H. Rodbard, K. Fox, 2010, Diabetes research and clinical practice.

A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

A. Shaunik, S. Grandy, K. Johnsson, 2016, Diabetes Therapy.

Underutilisation of cardiovascular medications among at‐risk individuals

K. Fox, S. Grandy, S. Lewis, 2010 .

Trends in Method of Diagnosis of Type 2 Diabetes Mellitus: Results from SHIELD

A. J. Green, H. Rodbard, K. Fox, 2009, International Journal of Endocrinology.

Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia*

K. Fox, S. Grandy, H. Bays, 2008 .

Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus.

A. J. Green, K. Fox, S. Grandy, 2012, Diabetes research and clinical practice.

Health and Quality of Life

K. Fox, S. Grandy, K. M. Fox, 2008 .

Self-reported diagnosis of heart disease: results from the SHIELD study

K. Fox, S. Grandy, S. Lewis, 2009, International journal of clinical practice.

Attitudes about health and health-related behaviors in patients with cardiovascular disease or at elevated risk for cardiovascular disease.

Jennifer G. Robinson, K. Fox, S. Grandy, 2009, Preventive cardiology.

Association of overweight and obesity with health status, weight management, and exercise behaviors among individuals with type 2 diabetes mellitus or with cardiometabolic risk factors

H. Rodbard, K. Fox, S. Grandy, 2009, Risk management and healthcare policy.

Quality of Life, Depression, and Healthcare Resource Utilization among Adults with Type 2 Diabetes Mellitus and Concomitant Hypertension and Obesity: A Prospective Survey

A. J. Green, K. Fox, S. Grandy, 2012, Cardiology research and practice.

A. J. Green, K. Fox, S. Grandy, 2007, International journal of clinical practice.

Patient Characteristics are not Associated with Clinically Important Differential Response to Dapagliflozin: a Staged Analysis of Phase 3 Data

S. Grandy, A. del Parigi, J. Sugg, 2014, Diabetes Therapy.

Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia.

K. Fox, S. Grandy, H. Bays, 2008, Current medical research and opinion.

Health and Quality of Life

A. Levy, S. Grandy, T. Christensen, 2008 .

PCV112 QUALITY OF LIFE AND DEPRESSION AMONG ADULTS WITH TYPE 2 DIABETES MELLITUS, HYPERTENSION, AND OBESITY

S. Grandy, K. Fox, 2010 .